PPD® Functional Service Partnership (FSP) Pharmacovigilance Solutions
Flexible solutions underscoring a commitment to patient safety
An unwavering dedication to excellence in patient safety is of the utmost importance for drug developers, but it can be a challenge to keep pace with evolving pharmacovigilance (PV) regulations and technologies. Success requires proactive engagement with industry changes — and an approach that places quality and innovation first — for products that are in development or on the market.
Whether you need a full global pharmacovigilance solution or discrete PV functions to complement your existing infrastructure, PPD® Functional Service Partnership (FSP) Pharmacovigilance solutions deliver the end-to-end capabilities you need to generate evidence that demonstrates the effectiveness, safety and value of your product.
Global resourcing maximizes pharmacovigilance operations to help clients meet their timelines
Breadth and depth of pharmacovigilance expertise
Experience matters, which is why over 900 biopharmaceutical, biotech and medical device organizations have turned to the PPD clinical research business of Thermo Fisher Scientific over the years for end-to-end pharmacovigilance solutions.
years of experience
companies supported since 1997
PV experts in 35 countries
endpoint dossiers adjudicated
The ease of a single, flexible, capable partner
By choosing an experienced, industry-leading functional service provider for your PV solutions, you gain a collaborator with a proven track record of stable, high-quality services and the convenience and ease of a single global partner.
With 25 years of PV and FSP expertise, PPD FSP pharmacovigilance solutions support all of your clinical trial and post-marketing service needs and bring robust therapeutic area experience and global expertise from more than 35 countries.
Integrated capabilities include: